PMV Pharmaceuticals Statistics Share Statistics PMV Pharmaceuticals has 52.99M
shares outstanding. The number of shares has increased by 0.84%
in one year.
Shares Outstanding 52.99M Shares Change (YoY) 0.84% Shares Change (QoQ) 0.04% Owned by Institutions (%) 71.84% Shares Floating 44.73M Failed to Deliver (FTD) Shares 1,108 FTD / Avg. Volume 0.32%
Short Selling Information The latest short interest is 803.93K, so 1.52% of the outstanding
shares have been sold short.
Short Interest 803.93K Short % of Shares Out 1.52% Short % of Float 1.79% Short Ratio (days to cover) 3.86
Valuation Ratios The PE ratio is -1.33 and the forward
PE ratio is -0.82.
PMV Pharmaceuticals's PEG ratio is
0.06.
PE Ratio -1.33 Forward PE -0.82 PS Ratio 0 Forward PS 26.5 PB Ratio 0.44 P/FCF Ratio -1.5 PEG Ratio 0.06
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for PMV Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 12.22,
with a Debt / Equity ratio of 0.01.
Current Ratio 12.22 Quick Ratio 12.22 Debt / Equity 0.01 Debt / EBITDA -0.02 Debt / FCF -0.02 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.25M Employee Count 47 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -16.1M Effective Tax Rate 21.52%
Stock Price Statistics The stock price has increased by -2.67% in the
last 52 weeks. The beta is 1.51, so PMV Pharmaceuticals's
price volatility has been higher than the market average.
Beta 1.51 52-Week Price Change -2.67% 50-Day Moving Average 1.38 200-Day Moving Average 1.28 Relative Strength Index (RSI) 51.48 Average Volume (20 Days) 342,924
Income Statement
Revenue n/a Gross Profit n/a Operating Income -85.45M Net Income -58.71M EBITDA -73.67M EBIT -74.81M Earnings Per Share (EPS) -1.14
Full Income Statement Balance Sheet The company has 40.88M in cash and 1.19M in
debt, giving a net cash position of 39.69M.
Cash & Cash Equivalents 40.88M Total Debt 1.19M Net Cash 39.69M Retained Earnings -368.71M Total Assets 152.85M Working Capital 133.7M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -51.28M
and capital expenditures -655K, giving a free cash flow of -51.94M.
Operating Cash Flow -51.28M Capital Expenditures -655K Free Cash Flow -51.94M FCF Per Share -1.01
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
